In Vitro Transcription Factor Binding DAP-Seq Service: Antibody-Free Target Discovery

DNA Affinity Purification Sequencing (DAP-Seq) is an in vitro assay that identifies transcription factor binding sites across the entire genome. It solves a major research bottleneck: the lack of highly specific antibodies. By expressing your target protein in a cell-free system, our in vitro transcription factor binding DAP-Seq service maps complex regulatory networks directly, completely bypassing the need for ChIP-grade antibodies.

Key Service Advantages:

  • 100% Antibody-Free Processing: Eliminates the exorbitant costs, extended timelines, and frequent failure risks associated with custom antibody generation.
  • Optimized Protein Expression: Utilizes a highly reliable HaloTag cell-free system to ensure proper protein folding and preserve natural DNA-binding activity.
  • Strict Quality Control Checkpoints: Mandatory Western blot verification confirms successful, full-length protein expression before any sequencing library preparation begins.
  • Publication-Ready Bioinformatics: Delivers comprehensive data packages including high-resolution peak calling, de novo motif discovery, and target gene annotation.
Get a Quote

Illustration of DAP-Seq combining cell-free protein expression with genomic DNA library screening

PDF Download
* Email Address:

CD Genomics needs the contact information you provide to us in order to contact you about our products and services and other content that may be of interest to you. By clicking below, you consent to the storage and processing of the personal information submitted above by CD Genomcis to provide the content you have requested.

×
x
Online Inquiry